Dr. Levine is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5090 N 40th St
Ste 250
Phoenix, AZ 85018Phone+1 602-258-3354
Education & Training
Washington University/B-JH/SLCH ConsortiumResidency, Neurology, 1994 - 1997- Washington University/B-JH/SLCH ConsortiumInternship, Internal Medicine, 1993 - 1994
Duke University School of MedicineClass of 1993
Certifications & Licensure
AZ State Medical License 1998 - 2027
MT State Medical License 2022 - 2026
WV State Medical License 2023 - 2026
WA State Medical License 2023 - 2026
VT State Medical License 2023 - 2026
UT State Medical License 2023 - 2026
TN State Medical License 2023 - 2026- American Board of Psychiatry and Neurology Neurology
- Join now to see all
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Combination Therapy in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2008 Jun 01
- Safety Study of High Doses of Zinc in ALS Patients Start of enrollment: 2010 Oct 01
- Dermatomyositis and Polymyositis Registry Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsEarly deterioration of CIDP following transition from IVIG to FcRn inhibitor treatment.Todd Levine, Suraj Muley
Journal of the Neurological Sciences. 2025-01-15 - Efficacy and safety of maintenance intravenous immunoglobulin in generalized myasthenia gravis patients with acetylcholine receptor antibodies: A multicenter, double-b...Vera Bril, Tomasz Berkowicz, Andrzej Szczudlik, Michael W Nicolle, Josef Bednarik
Muscle & Nerve. 2025-01-01 - A 40-week phase 2B randomized, multicenter, double-blind, placebo-controlled study evaluating the safety and efficacy of memantine in amyotrophic lateral sclerosis.Salman Bhai, Todd Levine, Dan Moore, Robert Bowser, Andrew J Heim
Muscle & Nerve. 2025-01-01
Press Mentions
CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative DiseasesDecember 18th, 2024- CND Life Sciences Announces Publication of Study Demonstrating Clinical Utility of the Syn-One Test® as an Important Aid in the Diagnosis and Treatment of Neurodegenerative DiseasesDecember 18th, 2024
Phase 2 Trial Testing H.P. Acthar Gel for ALS Enrolls Half of Patients, Still RecruitingJune 25th, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
